0 results available. Select is focused ,type to refine list, press Down to open the menu,
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the U...
The following section summarizes insights on Pacira Pharmaceuticals Inc's Basic EPS Growth:
We've identified the following companies as similar to Pacira Pharmaceuticals Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Basic EPS Growth in the growth category include:
Period over prior period growth in basic eps.
The basic eps incl extra items growth measures a company’s basic eps incl extra items year-over-year growth. The formula to calculate basic eps growth and an example calculation for Pacira BioSciences’s trailing twelve months is outlined below:
Basic EPS Growth = (Current Year - Prior Year) / ABS(Prior Year Basic EPS Incl Extra Items)*
−337.2% = (-$2.153 M - $907.684 T) / $907.684 T
*ABS = An absolute value adjustment is used to ensure the direction of growth of negative numbers is reflected
The tables below summarizes Pacira BioSciences’s performance over the last five years:
| Fiscal Year | Basic EPS Incl Extra Items | Growth |
|---|---|---|
| 2020-12-31 | 3.41 | 1,385.2% |
| 2021-12-31 | 0.95 | −72.2% |
| 2022-12-31 | 0.35 | −63.2% |
| 2023-12-31 | 0.91 | 159.7% |
| 2024-12-31 | -2.15 | −337.2% |
The tables below summarizes Pacira BioSciences’s performance over the last four quarters:
| Quarter Ending | Basic EPS Incl Extra Items | Growth |
|---|---|---|
| 2024-03-31 | 0.19 | 145.4% |
| 2024-06-30 | 0.41 | −26.8% |
| 2024-09-30 | -3.11 | −1,429.4% |
| 2024-12-31 | 0.35 | −35.1% |
Growth calculations are always made in the company’s reporting currency to ensure currency fluctuations do not impact the calculation. Pacira BioSciences’s reports in the USD currency. You can read more about Basic EPS Incl Extra Items here.
The chart above depicts the distribution of basic eps growth for companies operating in the Healthcare sector in the Developed economic region. Over 2,400 companies were considered in this analysis, and 2,310 had meaningful values. The average basic eps growth of companies in the sector is 7.4% with a standard deviation of 113.1%.
Pacira Pharmaceuticals Inc's Basic EPS Growth of -337.2% ranks in the 3.5% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,405 |
| Included Constituents | 2,310 |
| Min | -723.5% |
| Max | 379.0% |
| Median | 23.9% |
| Mean | 7.4% |
| Standard Deviation | 113.1% |
You can find companies with similar basic eps growth using this stock screener.